UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 99 filers reported holding UNITY BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $504,000 | -57.9% | 168,158 | -34.8% | 0.00% | -100.0% |
| Q2 2021 | $1,197,000 | +638.9% | 257,966 | +857.7% | 0.00% | – |
| Q1 2021 | $162,000 | +16.5% | 26,936 | +1.7% | 0.00% | – |
| Q4 2020 | $139,000 | +117.2% | 26,490 | +43.8% | 0.00% | – |
| Q3 2020 | $64,000 | -59.2% | 18,426 | +1.6% | 0.00% | – |
| Q2 2020 | $157,000 | +185.5% | 18,143 | +89.6% | 0.00% | – |
| Q1 2020 | $55,000 | -24.7% | 9,568 | -5.7% | 0.00% | – |
| Q4 2019 | $73,000 | +69.8% | 10,144 | +39.2% | 0.00% | – |
| Q3 2019 | $43,000 | -42.7% | 7,285 | -9.6% | 0.00% | – |
| Q2 2019 | $75,000 | -67.9% | 8,063 | -72.3% | 0.00% | – |
| Q1 2019 | $234,000 | -49.6% | 29,101 | +1.8% | 0.00% | – |
| Q4 2018 | $464,000 | +32.6% | 28,578 | +32.8% | 0.00% | – |
| Q3 2018 | $350,000 | +32.1% | 21,526 | +21.5% | 0.00% | – |
| Q2 2018 | $265,000 | – | 17,720 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 1,571,981 | $8,237,000 | 9.91% |
| Invus Financial Advisors, LLC | 1,094,998 | $5,738,000 | 2.40% |
| Founders Fund V Management, LLC | 491,751 | $2,577,000 | 0.66% |
| ALGERT GLOBAL LLC | 51,890 | $272,000 | 0.08% |
| Arbor Wealth Management, LLC | 25,888 | $136,000 | 0.05% |
| Moloney Securities Asset Management, LLC | 41,950 | $220,000 | 0.05% |
| PDT Partners, LLC | 78,800 | $413,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 394,957 | $2,070,000 | 0.02% |
| Fort Point Capital Partners LLC | 10,000 | $52,000 | 0.01% |
| Baillie Gifford | 3,803,014 | $19,928,000 | 0.01% |